Evaluation of a novel flow chamber system to assess clot formation in factor VIII-deficient mouse and anti-factor IXa-treated human blood.

Evaluation of a novel flow chamber system to assess clot formation in factor VIII-deficient mouse and anti-factor IXa-treated human blood.

Item
http://www.wikidata.org/entity/Q38324917
The effect of factor VIII deficiencies and replacement and bypass therapies on thrombus formation under venous flow conditions in microfluidic and computational modelsTotal Thrombus-Formation Analysis System (T-TAS) Can Predict Periprocedural Bleeding Events in Patients Undergoing Catheter Ablation for Atrial FibrillationMicrofluidic technology as an emerging clinical tool to evaluate thrombosis and hemostasis.Biomechanics of haemostasis and thrombosis in health and disease: from the macro- to molecular scaleFlow chamber and microfluidic approaches for measuring thrombus formation in genetic bleeding disorders.Application of microfluidic devices in studies of thrombosis and hemostasis.Rate-limiting roles of the tenase complex of factors VIII and IX in platelet procoagulant activity and formation of platelet-fibrin thrombi under flow.Usefulness of the Total Thrombus-Formation Analysis System (T-TAS) in the diagnosis and characterization of von Willebrand disease.Role of red blood cells in the anemia-associated bleeding under high shear conditions.Recombinant factor VIIa addition to haemophilic blood perfused over collagen/tissue factor can sufficiently bypass the factor IXa/VIIIa defect to rescue fibrin generation.Comprehensive evaluation of haemostatic function in von Willebrand disease patients using a microchip-based flow chamber system.Assessment of platelet-derived thrombogenicity with the total thrombus-formation analysis system in coronary artery disease patients receiving antiplatelet therapy.Use of a microchip flow-chamber system as a screening test for platelet storage pool disease.
P2860

Evaluation of a novel flow chamber system to assess clot formation in factor VIII-deficient mouse and anti-factor IXa-treated human blood.

Item
http://www.wikidata.org/entity/Q38324917
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Evaluation of a novel flow cha ...... actor IXa-treated human blood.
@en
type
label
Evaluation of a novel flow cha ...... actor IXa-treated human blood.
@en
prefLabel
Evaluation of a novel flow cha ...... actor IXa-treated human blood.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Evaluation of a novel flow cha ...... factor IXa-treated human blood
@en
P2093
P304
P31
P356
10.1111/J.1365-2516.2012.02867.X
P433
P478
P50
P577
P5875
P698